🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparative Effects of Blood Flow Restriction Resistance Training Versus Blood Flow Restriction Cycling on Pain, Quadriceps Strength, and Functional Outcomes in Athletes With Patellofemoral Pain

RecruitingNAAges 18 Years - 40 YearsAllIbadat International University, Islamabad
NCT07585305 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized controlled trial compares blood flow restriction (BFR) resistance training (leg press and seated knee extension at 30% 1RM) versus BFR cycling (stationary cycling at low resistance) in 60 athletes (aged 18-40 years) diagnosed with patellofemoral pain syndrome. Both interventions are delivered over 8 weeks (3 sessions/week) with a pneumatic cuff set at 80% limb occlusion pressure. Primary outcomes include pain intensity (NPRS), quadriceps strength (handheld dynamometer), and functional ability (Kujala Anterior Knee Pain Scale), assessed at baseline and post-intervention.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Male and female athletes aged 18-40 years 2. Clinically diagnosed with patellofemoral pain syndrome 3. Anterior or retropatellar knee pain of at least 3 months duration 4. Pain provoked by at least two functional activities (e.g., squatting, stair climbing, running, prolonged sitting) 5. Willingness to participate and provide written informed consent Exclusion Criteria: 1. History of knee surgery or significant knee trauma in the past 6 months 2. Presence of ligament, meniscal, or cartilage injuries 3. Neurological, vascular, or systemic inflammatory conditions 4. Contraindications to BFR training (e.g., deep vein thrombosis, uncontrolled hypertension) 5. Pregnancy
💊

What it tests

  • Blood Flow Restriction Resistance Training
  • Blood Flow Restriction Cycling
📍

Where

1 site
Ibadat International University, Islamabad (Iiui)
Islamabad, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy